Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Prevalence, Clinical Characteristics and Outcome of Von Willebrand Disease in Oman

Shamsa Alkaabi, Aala Alzadjali, Mustafa Wasifuddin, Ibrahim Suliman Masoud Alghaithi, MD, Murtadha Al-Khabori, MD, Anil Pathare, MD PhD FCPS, MBBS, Yasser Wali, MD

Blood (2019) 134 (Supplement_1): 4939.

https://doi.org/10.1182/blood-2019-123915

Published: 2019

Journal Articles

A Regional Massive Hemorrhage Protocol: Designed with a Modified Delphi Technique to Obtain Consensus

Jeannie Callum, Calvin Yeh, MD PhD, Mark McVey, MD, Andrew Petrosoniak, MD, Stephanie Cope, Troy Thompson, BAHSc, Victoria Chin, Keyvan Karkouti, MD, Avery Nathans, MDMPH PhD, Kimmo Murto, MD, Suzanne Beno, MD, Jacob Pendergrast, MDFRCPC, Andrew McDonald, MDMSc, Neil Adhikari, MDM MSc, Asim Alam, MD, Donald M. Arnold, MD, Lee Barratt, Andrew Beckett, MD, Sue Brenneman, MD, Hina Chaudhry, BSc, Allison Collins, MD, Margaret Harvey, Jacinthe Lampron, MD, Russell MacDonald, MDMPH, Clarita Margarido, MD, Amanda McFarlan, Barto Nascimento, MDMSc, Wendy Owens, Menaka Pai, MSc, MD FRCPC, Sandro Rizoli, MD PhD, Theodora Ruijs, MD, Robert Skeate, PhD, Teresa Skelton, MD, Michelle Sholzberg, MDBSc,FRCPC,MSc, Kelly Syer, Jami-Lynn Viveiros, Josee Theriault, MD, Alan T. Tinmouth, MD FRCPC, Rardi Van Heest, MD, Susan White, Michelle P. Zeller, MD FRCPC, MHPE, Katerina Pavenski, MD

Blood (2019) 134 (Supplement_1): 5792.

https://doi.org/10.1182/blood-2019-121501

Published: 2019

Journal Articles

Clinical, Laboratory and Molecular Characterization of Factor VII, Factor X and Their Combined Deficiencies in a Tertiary Care Center

Bereczky Zsuzsanna, MD PhD, Speker Marianna, Al-Muhanna Marie, Balogh Gábor, Boda Zoltán, MD PhD DSc, Pfliegler György, MD PhD, Schlammadinger Ágota, MD PhD, Kerényi Adrienn, MD PhD, Csongor Kiss, MD PhD DSc

Blood (2019) 134 (Supplement_1): 2394.

https://doi.org/10.1182/blood-2019-125504

Published: 2019

Journal Articles

Recombinant Porcine Factor VIII Use in Bleed Treatment in Non-Severe Hemophilia a Inhibitor Patients: Dosing Strategies and Efficacy

Patrick Ellsworth, MD, Sheh-Li Chen, PharmD, Yasmina L. Abajas, MD, Stephan Moll, MD, Nigel S. Key, MBChB, FRCP, Alice D. Ma, MD

Blood (2018) 132 (Supplement 1): 1202.

https://doi.org/10.1182/blood-2018-99-119196

Published: 2018

Journal Articles

Successful Treatment of Bleeding in Acquired Hemophilia A with Activated Prothrombin Complex Concentrate in Spain

Maria Eva Mingot-Castellano, PhD MD, Rocio Pérez-Montes, MD, Mariana Canaro, PhD MD, Ana Marco, PhD MD, Victoria Calle-Gordo, MD, Ana Isabel Heiniger, MD

Blood (2017) 130 (Supplement 1): 3688.

https://doi.org/10.1182/blood.V130.Suppl_1.3688.3688

Published: 2017

Journal Articles

Anticoagulant Actions of Recombinant Thrombomodulin and Activated Protein C and Their Neutralization By Factor VIII Inhibitor Bypass Activity (FEIBA)

Walter Jeske, Mary Lewis, Parul Aggarwal, Zafar Siddiqui, Omer Iqbal, Debra Hoppensteadt, PhD, Kazuhisa Tsuruta, Jawed Fareed, PhD, Sid Mehrota

Blood (2017) 130 (Supplement 1): 4905.

https://doi.org/10.1182/blood.V130.Suppl_1.4905.4905

Published: 2017

Journal Articles

Individualized Prophylactic Treatment with Recombinant Factor VIII in Severe or Moderate Haemophilia a Patients. Association Between Pharmacokinetic Parameters and Clinical Variables

Juan Eduardo Megías-Vericat, PharmD, María Remedios Marqués, PhD, Saturnino Haya, MD, Ana Rosa Cid, MD, Felipe Querol, MD, Emilio Monte, PhD, María García-Dasí, Patricia Caunedo, Carmen Vila, Pau Bosch, Rafael Curats, Miguel Ángel Sanz, MD PhD, José Luis Poveda, PhD, Santiago Bonanad, MD

Blood (2016) 128 (22): 3802.

https://doi.org/10.1182/blood.V128.22.3802.3802

Published: 2016

Journal Articles

Case-Control Pilot Study of the Immune Modulating Effect of FEIBA ® on Patients with Haemophilia a and Inhibitors

Ihosvany Fernandez Bello, PhD, María Teresa Álvarez Román, PhD, Victor Jiménez Yuste, PhD, Monica Martín Salces, Gemma Iruin, PhD, Santiago Bonanad, PhD, María Fernanda López Fernández, PhD, Carmen Altisent, PhD, Faustino García Candel, PhD, María Isabel Rivas Pollmar, Miguel Canales, PhD, Nora Butta, PhD

Blood (2015) 126 (23): 4688.

https://doi.org/10.1182/blood.V126.23.4688.4688

Published: 2015

Journal Articles

A Prospective Evaluation of Acute Traumatic Coagulopathy and Effects of Damage Control Resuscitation in Military Trauma Patients in Afghanistan

Zachary Edward Wright, MD, Ian Stewart, MD, Jonathan Sosnov, MD, Heather F Pidcoke, MD PhD, Fedyk Chriselda, MS, Hana Kwan, MD, Kelly Heegard, MD, Christopher White, MD, Kevin Chung, MD, Andrew P Cap, MDPhD

Blood (2014) 124 (21): 2848.

https://doi.org/10.1182/blood.V124.21.2848.2848

Published: 2014

Journal Articles

Bleeding Phenotype with Various Bay 94-9027 Dosing Regimens: Subanalyses from the Protect VIII Study

Lisa N. Boggio, Walter Hong, Maria Wang, M. Elaine Eyster, MD, Lisa A. Michaels

Blood (2014) 124 (21): 1526.

https://doi.org/10.1182/blood.V124.21.1526.1526

Published: 2014

Journal Articles

Use Of Prothrombin Complex Concentrates In Patients With Hepatic Coagulopathy: A Single Center Retrospective

Guillaume Richard-Carpentier, MD, Normand Blais, MD, MSC, FRCPC, Benjamin Rioux-Masse, MD, FRCPC

Blood (2013) 122 (21): 2400.

https://doi.org/10.1182/blood.V122.21.2400.2400

Published: 2013

Journal Articles

Factor XIII Deficiency As Underlying Cause Of Unexplained Bleeding

Marta Ruiz Mercado, Silvia Verdesoto Cozzarelli, Cristina Calderón-Cabrera, Ramiro Núñez Vázquez, Reyes Jiménez Bárcenas, Rosario Pérez Garrido, Jose Antonio Pérez-Simón, Francisco Javier Rodríguez Martorell

Blood (2013) 122 (21): 4776.

https://doi.org/10.1182/blood.V122.21.4776.4776

Published: 2013

Journal Articles

Low-Dose Combined Immunosuppression Results In Rapid Remission In Patients With Acquired Hemophilia A

Andrea Várkonyi, MD, Attila Szederjesi, János Dolgos, MD, Péter Farkas, MD, Júlia Galgóczi, Kinga Káel, Katalin Pap, Krisztina Szabó, Beata Vilimi, MD, Tamás Masszi, MD, PhD, Imre Bodó, MD, PhD

Blood (2013) 122 (21): 3589.

https://doi.org/10.1182/blood.V122.21.3589.3589

Published: 2013

Journal Articles

Recombinant B-Domain Deleted Porcine Factor VIII (OBI-1) Safety and Efficacy in the Treatment of Acquired Hemophilia A: Interim Results.

Jean St. Louis, MD, Rebecca Kruse-Jarres, MD/MPH, Anne Greist, MD, Amy D. Shapiro, MD, Hedy Smith, MD PhD, Anja B Drebes, MRCP, FRCPath, Jay N. Lozier, MD, PhD, Edward D. Gomperts, MD

Blood (2012) 120 (21): 2224.

https://doi.org/10.1182/blood.V120.21.2224.2224

Published: 2012

Journal Articles

Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry

Francesco Baudo, Peter Collins, Angela Huth-Kühne, Hervé Lévesque, Pascual Marco, László Nemes, Fabio Pellegrini, Lilian Tengborn, Paul Knoebl

Blood (2012) 120 (1): 39–46.

https://doi.org/10.1182/blood-2012-02-408930

Published: 2012

Includes: Supplemental data

Journal Articles

Sequential Therapy with Activated Prothrombin Complex Concentrates and Recombinant Factor VIIa in the Treatment of Unresponsive Bleeding in Patients with Hemophilia and Inhibitors

Young shil Park, M.D., Yong-Mook Choi, M.D., Ji Kyoung Park, M.D.

Blood (2011) 118 (21): 4664.

https://doi.org/10.1182/blood.V118.21.4664.4664

Published: 2011

Journal Articles

Sequential Combined Bypassing Therapy (SCBT) Is Safe and Effective in the Treatment of Unresponsive Bleeding in Adults and Children with Haemophilia and Inhibitors.

Alessandro Gringeri, MD, MSc, Kathelijn Fischer, MD, PhD, MSc, Anastasia Karafoulidou, MD, Robert Klamroth, MD, Maria Fernanda Lopez, MD, Maria Elisa Mancuso, MD

Blood (2009) 114 (22): 1294.

https://doi.org/10.1182/blood.V114.22.1294.1294

Published: 2009

Journal Articles

Recombinant Activated Factor VII (rFVIIa) Dosing and Efficacy in the Treatment of Cranial Hemorrhage in Hemophilia Patients with Inhibitors: An Analysis of the Hemophilia and Thrombosis Research Society Registry (HTRS) (2004–2008).

Charles T Nakar, MD, David L. Cooper, MD, MBA, Donna DiMichele, MD

Blood (2008) 112 (11): 2278.

https://doi.org/10.1182/blood.V112.11.2278.2278

Published: 2008

Journal Articles

Response Rates of High and Low Dose Estrogen and Their Combination with DDAVP and/or Aminocaproic Acid in Patients with Menorrhagia and Type I Von Willebrand’s Disease.

Vasundhara Kailasnath, M.D., S. Paige Hertweck, M.D., Salvatore Bertolone, MD, Sanjay P Ahuja, MD

Blood (2008) 112 (11): 3391.

https://doi.org/10.1182/blood.V112.11.3391.3391

Published: 2008

Journal Articles

Internal and External Determinants of Bleeding Patterns on Prophylaxis for Severe Haemophilia A.

Kathelijn Fischer, MD, PhD, Peter Collins, MD, Jan Astermark, MD, Victor S. Blanchette, MD, Sven Bjorkman, PhD, Myungshin Oh, PhD, Phillip Schroth, Sandor Fritsch, PhD, Kathleen M. Casey, PhD, Gerald Spotts, PhD, Bruce M. Ewenstein, MD, PhD

Blood (2007) 110 (11): 1145.

https://doi.org/10.1182/blood.V110.11.1145.1145

Published: 2007

NARROW

Prevalence, Clinical Characteristics and Outcome of Von Willebrand Disease in Oman

A Regional Massive Hemorrhage Protocol: Designed with a Modified Delphi Technique to Obtain Consensus

Clinical, Laboratory and Molecular Characterization of Factor VII, Factor X and Their Combined Deficiencies in a Tertiary Care Center

Recombinant Porcine Factor VIII Use in Bleed Treatment in Non-Severe Hemophilia a Inhibitor Patients: Dosing Strategies and Efficacy

Successful Treatment of Bleeding in Acquired Hemophilia A with Activated Prothrombin Complex Concentrate in Spain

Anticoagulant Actions of Recombinant Thrombomodulin and Activated Protein C and Their Neutralization By Factor VIII Inhibitor Bypass Activity (FEIBA)

Individualized Prophylactic Treatment with Recombinant Factor VIII in Severe or Moderate Haemophilia a Patients. Association Between Pharmacokinetic Parameters and Clinical Variables

Case-Control Pilot Study of the Immune Modulating Effect of FEIBA ® on Patients with Haemophilia a and Inhibitors

A Prospective Evaluation of Acute Traumatic Coagulopathy and Effects of Damage Control Resuscitation in Military Trauma Patients in Afghanistan

Bleeding Phenotype with Various Bay 94-9027 Dosing Regimens: Subanalyses from the Protect VIII Study

Use Of Prothrombin Complex Concentrates In Patients With Hepatic Coagulopathy: A Single Center Retrospective

Factor XIII Deficiency As Underlying Cause Of Unexplained Bleeding

Low-Dose Combined Immunosuppression Results In Rapid Remission In Patients With Acquired Hemophilia A

Recombinant B-Domain Deleted Porcine Factor VIII (OBI-1) Safety and Efficacy in the Treatment of Acquired Hemophilia A: Interim Results.

Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry

Sequential Therapy with Activated Prothrombin Complex Concentrates and Recombinant Factor VIIa in the Treatment of Unresponsive Bleeding in Patients with Hemophilia and Inhibitors

Sequential Combined Bypassing Therapy (SCBT) Is Safe and Effective in the Treatment of Unresponsive Bleeding in Adults and Children with Haemophilia and Inhibitors.

Recombinant Activated Factor VII (rFVIIa) Dosing and Efficacy in the Treatment of Cranial Hemorrhage in Hemophilia Patients with Inhibitors: An Analysis of the Hemophilia and Thrombosis Research Society Registry (HTRS) (2004–2008).

Response Rates of High and Low Dose Estrogen and Their Combination with DDAVP and/or Aminocaproic Acid in Patients with Menorrhagia and Type I Von Willebrand’s Disease.

Internal and External Determinants of Bleeding Patterns on Prophylaxis for Severe Haemophilia A.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only